ACTRN12613001304729招募中未知
A multicentre, observational, prospective study of the current practice in major centres in Australia and New Zealand for achieving haemostasis in consecutive patients who present with significant haemorrhage, thromboembolism or urgent surgery whilst on new or established oral anticoagulants
ARES Collaborative0 个研究点目标入组 2,000 人开始时间: 2013年11月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- o limit 至 o limit（—）
- 性别
- All
入选标准
- •Patients presenting with significant haemorrhage, thromboembolism or require anticoagulation reversal for urgent surgery and/or a procedure and have taken a NOAC (dabigatran, rivaroxaban, or apixaban) or warfarin within the last 7 days.
排除标准
- •Patients who have minor haemorrhage responding to local measures not requiring admission, blood testing or change in anticoagulant management.
- •Patients who are unable to have objective testing for recurrence of thromboembolism.
研究者
相似试验
尚未招募
不适用
A multicenter, prospective observational study of new criteria for sepsis (Sepsis-3)Sepsis (sepsis-3 criteria)JPRN-UMIN000036349Japanese Association for Acute Medicine600
已完成
不适用
A multicenter, prospective observational study of treatment and prognosis in patients with primary small bowel cancerSmall bowel cancerJPRN-UMIN000030361ational Hospital Organization Okayama Medical Center54
已完成
不适用
A multicenter, prospective observational study of pegfilgrastim for the management of febrile neutropenia during ramucirumab plus docetaxel for patients with advanced non-small cell lung cancer (CJLSG 1602)non-small cell lung cancerJPRN-UMIN000026927Central Japan Lung Study Group (CJLSG)35
招募中
不适用
A prospective, multicenter, observational study of the effects of SGLT2 inhibitors/ SPPARMalpha combination therapy on liver function in patients with type 2 diabetes and dyslipidemiatype 2 diabetes and dyslipidemiaJPRN-UMIN000043716niversity of Miyazaki50
招募中
Unknown
Polatuzumab vedotin plus R-CHP therapy in patients with previously untreated diffuse large B-cell lymphomaDiffuse large B-cell lymphomDLBCDLBCLJPRN-jRCT1071220082Kato Koji500